Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Gross Profit (2017 - 2025)

Historic Gross Profit for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $42.3 million.

  • Puma Biotechnology's Gross Profit fell 1777.24% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year decrease of 338.88%. This contributed to the annual value of $166.1 million for FY2024, which is 398.43% down from last year.
  • As of Q3 2025, Puma Biotechnology's Gross Profit stood at $42.3 million, which was down 1777.24% from $40.1 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Gross Profit ranged from a high of $70.8 million in Q4 2022 and a low of $33.0 million during Q1 2024
  • Its 5-year average for Gross Profit is $44.3 million, with a median of $42.7 million in 2023.
  • Over the last 5 years, Puma Biotechnology's Gross Profit had its largest YoY gain of 6291.93% in 2022, and its largest YoY loss of 4914.59% in 2022.
  • Over the past 5 years, Puma Biotechnology's Gross Profit (Quarter) stood at $43.5 million in 2021, then soared by 62.92% to $70.8 million in 2022, then plummeted by 32.42% to $47.9 million in 2023, then dropped by 5.64% to $45.2 million in 2024, then decreased by 6.32% to $42.3 million in 2025.
  • Its Gross Profit stands at $42.3 million for Q3 2025, versus $40.1 million for Q2 2025 and $35.5 million for Q1 2025.